First Time Loading...

Chengdu Kanghong Pharmaceutical Group Co Ltd
SZSE:002773

Watchlist Manager
Chengdu Kanghong Pharmaceutical Group Co Ltd Logo
Chengdu Kanghong Pharmaceutical Group Co Ltd
SZSE:002773
Watchlist
Price: 22.39 CNY -0.75% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Chengdu Kanghong Pharmaceutical Group Co Ltd?
Write Note

P/E
Price to Earnings

18.1
Current
18
Median
22.1
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
18.1
=
Market Cap
20.6B
/
Net Income
1.1B
All Countries
Close

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
17.1
2-Years Forward
P/E
14.2
3-Years Forward
P/E
N/A

See Also

Discover More